Understanding the mechanism of PLA2G2A in MIS-C pathophysiology is crucial because PLA2G2A and its associated pathways can be targeted with the common, inexpensive medication indomethacin47. This evidence concerns the gene PLA2G2A and COVID-19–associated multisystem inflammatory syndrome in children.